Kapur Raj P
Department of Laboratories, Seattle Children's Hospital, Seattle, WA, USA.
Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
Pediatr Dev Pathol. 2023 Jan-Feb;26(1):39-51. doi: 10.1177/10935266221128133. Epub 2022 Dec 26.
Pathogenic mutations in the smooth muscle myosin heavy chain gene, , cause megacystis megacolon intestinal hypoperistalsis syndrome and other forms of chronic intestinal pseudo-obstruction. Evaluation of intestinal tissues from affected patients is often performed before mutational analysis, but the pathological findings of -variant visceral myopathy have not been well defined.
Light microscopic, immunohistochemical, and ultrastructural findings from multiple intestinal samples from 2 patients with MYH11-variant visceral myopathy were reviewed, including MYH11-specific immunohistochemistry. The findings were compared with intestinal samples from patients with gamma-smooth muscle actin ()-variant visceral myopathy and non-pseudo-obstruction controls.
Apart from non-specific changes (e.g., muscle hypertrophy and distension-related muscularis propria necrosis), no alterations were identified by routine histopathological evaluation or electron microscopy. Immunohistochemistry with antibodies against a battery of smooth muscle proteins, including MYH11, revealed indistinguishable patterns of immunoreactivity in the muscularis propria of both patients and controls.
Myopathic morphological or immunohistochemical changes may not be present in intestinal specimens from patients with -variant visceral myopathy. Molecular genetic studies should be considered for patients with chronic intestinal pseudo-obstruction and normal or non-specific pathology findings.
平滑肌肌球蛋白重链基因()中的致病性突变会导致巨膀胱-巨结肠-肠道蠕动功能减退综合征及其他形式的慢性肠道假性梗阻。在进行突变分析之前,通常会对受影响患者的肠道组织进行评估,但MYH11变异型内脏肌病的病理表现尚未明确界定。
回顾了2例MYH11变异型内脏肌病患者多个肠道样本的光镜、免疫组化和超微结构结果,包括MYH11特异性免疫组化。将这些结果与γ-平滑肌肌动蛋白()变异型内脏肌病患者和非假性梗阻对照的肠道样本进行比较。
除了非特异性改变(如肌肉肥大和与扩张相关的固有肌层坏死)外,常规组织病理学评估或电子显微镜检查未发现其他改变。使用针对一系列平滑肌蛋白(包括MYH11)的抗体进行免疫组化,结果显示患者和对照的固有肌层中免疫反应模式无明显差异。
MYH11变异型内脏肌病患者的肠道标本中可能不存在肌病形态学或免疫组化改变。对于慢性肠道假性梗阻且病理结果正常或非特异性的患者,应考虑进行分子遗传学研究。